Patents by Inventor Gregory L. Conn

Gregory L. Conn has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • DNA molecules encoding vascular endothelial cell growth factor II subunits
    Patent number: 6933134
    Abstract: Vascular endothelial cell growth factor II is purified from the culture media used to maintain mammalian glioma cells. The protein is a heterodimer, stimulates mitogenesis of mammalian vascular endothelial cells and is useful for the promotion of vascular development and repair. This unique growth factor is also useful in the promotion of tissue repair.
    Type: Grant
    Filed: February 8, 2002
    Date of Patent: August 23, 2005
    Assignee: Merck & Co., Inc.
    Inventors: Marvin L. Bayne, Gregory L. Conn, Kenneth A. Thomas, Jr.
  • DNA molecules encoding vascular endothelial cell growth factor II subunits
    Publication number: 20030045471
    Abstract: Vascular endothelial cell growth factor II is purified from the culture media used to maintain mammalian glioma cells. The protein is a heterodimer, stimulates mitogenesis of mammalian vascular endothelial cells and is useful for the promotion of vascular development and repair. This unique growth factor is also useful in the promotion of tissue repair.
    Type: Application
    Filed: February 8, 2002
    Publication date: March 6, 2003
    Applicant: Merck & Co., Inc.
    Inventors: Marvin L. Bayne, Gregory L. Conn, Kenneth A. Thomas
  • Vascular endothelial cell growth factor II
    Patent number: 6180107
    Abstract: Vascular endothelial cell growth factor II is purified from the culture media used to maintain mammalian glioma cells. The protein is a heterodimer, stimulates mitogenesis of mammalian vascular endothelial cells and is useful for the promotion of vascular development and repair. This unique growth factor is also useful in the promotion of tissue repair.
    Type: Grant
    Filed: March 10, 1998
    Date of Patent: January 30, 2001
    Assignee: Merck & Co., Inc.
    Inventors: Marvin L. Bayne, Gregory L. Conn, Kenneth A. Thomas, Jr.
  • Vascular endothelial cell growth factor II
    Patent number: 5726152
    Abstract: Vascular endothelial cell growth factor II is purified from the culture media used to maintain mammalian glioma cells. The protein is a heterodimer, stimulates mitogenesis of mammalian vascular endothelial cells and is useful for the promotion of vascular development and repair. This unique growth factor is also useful in the promotion of tissue repair.
    Type: Grant
    Filed: August 31, 1994
    Date of Patent: March 10, 1998
    Assignee: Merck & Co., Inc.
    Inventors: Marvin L. Bayne, Gregory L. Conn, Kenneth A. Thomas, Jr.
  • Purification and characterization of a glioma-derived growth factor having vascular endothelial cell growth promoting activity
    Patent number: 5532343
    Abstract: Glioma-derived growth factor is purified from the culture media used to maintain mammalian glioma cells. The protein stimulates mitogenesis of mammalian vascular endothelial cells and is useful for the promotion of vascular development and repair. This unique growth factor is also useful in the promotion of tissue repair.
    Type: Grant
    Filed: March 2, 1994
    Date of Patent: July 2, 1996
    Assignee: Merck & Co., Inc.
    Inventors: Marvin L. Bayne, Kenneth A. Thomas, Jr., Gregory L. Conn
  • DNA encoding glioma-derived growth factor having vascular endothelial cell growth promoting activity
    Patent number: 5338840
    Abstract: Glioma-derived growth factor is purified from the culture media used to maintain mammalian glioma cells. The protein stimulates mitogenesis of mammalian vascular endothelial cells and is useful for the promotion of vascular development and repair. This unique growth factor is also useful in the promotion of tissue repair.
    Type: Grant
    Filed: May 27, 1992
    Date of Patent: August 16, 1994
    Assignee: Merck & Co., Inc.
    Inventors: Marvin L. Bayne, Kenneth A. Thomas, Jr., Gregory L. Conn